Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.46B |
| 2 |
NVIDIA
NVDA
|
+$1.08B |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$609M |
| 4 |
Moderna
MRNA
|
+$599M |
| 5 |
UBS Group
UBS
|
+$478M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.11B |
| 2 |
Apple
AAPL
|
+$679M |
| 3 |
Palo Alto Networks
PANW
|
+$450M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$428M |
| 5 |
Microsoft
MSFT
|
+$361M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.97% |
| 2 | Financials | 8.75% |
| 3 | Healthcare | 7.15% |
| 4 | Consumer Discretionary | 6.46% |
| 5 | Communication Services | 5.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3026
United Fire Group
UFCS
$1.32B
| $685K | ﹤0.01% |
29,528
+10,434
| +55% | +$234K |
|
3027
First Bancorp
FNLC
$396M
| $683K | ﹤0.01% |
21,737
+8,336
| +62% | +$253K |
|
3028
PUT
Vistra
VST
$50B
| $683K | ﹤0.01% |
30,000
| – | – |
|
3029
Freshpet
FRPT
$2.93B
| $681K | ﹤0.01% |
7,148
-5,147
| -42% | -$638K |
|
3030
Dorian LPG
LPG
$2.03B
| $680K | ﹤0.01% |
53,619
+2,619
| +5% | +$33.1K |
|
3031
Central Garden & Pet Co
CENT
$2.69B
| $677K | ﹤0.01% |
16,069
+6,281
| +64% | +$258K |
|
3032
Talos Energy
TALO
$2.53B
| $677K | ﹤0.01% |
69,054
+13,329
| +24% | +$152K |
|
|
THR
3033
DELISTED
Thermon Group Holdings
THR
| $677K | ﹤0.01% |
40,008
+26,538
| +197% | +$464K |
|
|
ALX
3034
Alexander's
ALX
$1.3B
| $676K | ﹤0.01% |
2,597
+1,361
| +110% | +$365K |
|
3035
Anika Therapeutics
ANIK
$258M
| $676K | ﹤0.01% |
18,846
+6,193
| +49% | +$248K |
|
3036
UNIFI
UFI
$119M
| $676K | ﹤0.01% |
29,192
+7,119
| +32% | +$162K |
|
3037
Mercantile Bank Corp
MBWM
$1.04B
| $674K | ﹤0.01% |
19,256
+12,260
| +175% | +$427K |
|
3038
Meridian
MRBK
$234M
| $672K | ﹤0.01% |
36,538
-1,246
| -3% | -$20.6K |
|
|
NBIS
3039
CALL
Nebius Group N.V.
NBIS
$48.3B
| $672K | ﹤0.01% |
11,100
| – | – |
|
|
GTHX
3040
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $669K | ﹤0.01% |
65,513
+48,788
| +292% | +$622K |
|
|
NWLI
3041
DELISTED
National Western Life Group, Inc. Class A
NWLI
| $668K | ﹤0.01% |
3,113
+1,874
| +151% | +$408K |
|
3042
REX American Resources
REX
$1.42B
| $665K | ﹤0.01% |
41,574
+9,618
| +30% | +$147K |
|
|
EBTC
3043
DELISTED
Enterprise Bancorp
EBTC
| $664K | ﹤0.01% |
14,784
+7,463
| +102% | +$296K |
|
|
RBNC
3044
DELISTED
Reliant Bancorp, Inc. Common Stock
RBNC
| $663K | ﹤0.01% |
18,682
-25,522
| -58% | -$868K |
|
3045
CALL
AMN Healthcare
AMN
$1.3B
| $661K | ﹤0.01% |
+5,400
| New | +$600K |
|
3046
Cass Information Systems
CASS
$714M
| $661K | ﹤0.01% |
16,808
+10,818
| +181% | +$459K |
|
3047
Citizens
CIA
$239M
| $661K | ﹤0.01% |
124,462
+40,189
| +48% | +$246K |
|
|
AGTI
3048
DELISTED
Agiliti Inc
AGTI
| $661K | ﹤0.01% |
28,529
+18,924
| +197% | +$415K |
|
3049
HCI Group
HCI
$2.23B
| $659K | ﹤0.01% |
7,882
+2,591
| +49% | +$302K |
|
|
HAYN
3050
DELISTED
Haynes International, Inc.
HAYN
| $659K | ﹤0.01% |
16,338
+6,279
| +62% | +$255K |
|
Similar funds
Barclays's Q4 2021 Portfolio in Review
As of Q4 2021, Barclays held 5,008 positions worth $268B, up 21% from $222B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Barclays deployed $30.5B of net new capital in Q4 2021, opening 209 new positions and adding to 2,223 existing holdings. Its largest new stake was UBS Group: 27,173,428 shares worth $486M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.11B trimmed.
- Barclays's largest Q4 2021 buy was UBS Group: 27,173,428 shares worth $486M.
- Barclays added most to iShares 20+ Year Treasury Bond ETF in Q4 2021, an estimated $1.46B increase.
- Barclays's biggest Q4 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.11B.
- Barclays fully exited Vanguard Total International Bond ETF in Q4 2021, selling an estimated $89.8M.
- Barclays's ten largest holdings make up 30% of its $268B portfolio in Q4 2021.
- Barclays opened 209 new positions and closed 867 in Q4 2021.
- Barclays's portfolio value rose 21% quarter-over-quarter to $268B.
Based on Barclays's 13F filing for Q4 2021, filed 14 Feb 2022.